nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP2A6—Methimazole—Graves' disease	0.312	0.377	CbGbCtD
Progesterone—CYP2C19—Methimazole—Graves' disease	0.129	0.156	CbGbCtD
Progesterone—CYP1A2—Methimazole—Graves' disease	0.119	0.144	CbGbCtD
Progesterone—CYP2C9—Methimazole—Graves' disease	0.107	0.13	CbGbCtD
Progesterone—CYP2D6—Methimazole—Graves' disease	0.0982	0.119	CbGbCtD
Progesterone—CYP3A4—Methimazole—Graves' disease	0.0624	0.0754	CbGbCtD
Progesterone—Erythema nodosum—Propylthiouracil—Graves' disease	0.0103	0.0933	CcSEcCtD
Progesterone—Neuritis—Methimazole—Graves' disease	0.007	0.0636	CcSEcCtD
Progesterone—Neuritis—Propylthiouracil—Graves' disease	0.00595	0.0541	CcSEcCtD
Progesterone—Lymphadenopathy—Methimazole—Graves' disease	0.00445	0.0404	CcSEcCtD
Progesterone—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00378	0.0343	CcSEcCtD
Progesterone—Hepatic failure—Propylthiouracil—Graves' disease	0.00359	0.0326	CcSEcCtD
Progesterone—Drowsiness—Methimazole—Graves' disease	0.00292	0.0266	CcSEcCtD
Progesterone—Neuropathy peripheral—Methimazole—Graves' disease	0.00287	0.026	CcSEcCtD
Progesterone—Jaundice—Methimazole—Graves' disease	0.00285	0.0259	CcSEcCtD
Progesterone—Hepatitis—Methimazole—Graves' disease	0.00263	0.0238	CcSEcCtD
Progesterone—CYP17A1—connective tissue—Graves' disease	0.00261	0.0425	CbGeAlD
Progesterone—Drowsiness—Propylthiouracil—Graves' disease	0.00249	0.0226	CcSEcCtD
Progesterone—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00244	0.0221	CcSEcCtD
Progesterone—Jaundice—Propylthiouracil—Graves' disease	0.00242	0.022	CcSEcCtD
Progesterone—Alopecia—Methimazole—Graves' disease	0.00232	0.0211	CcSEcCtD
Progesterone—Haemoglobin—Propylthiouracil—Graves' disease	0.00224	0.0204	CcSEcCtD
Progesterone—Hepatitis—Propylthiouracil—Graves' disease	0.00223	0.0203	CcSEcCtD
Progesterone—Haemorrhage—Propylthiouracil—Graves' disease	0.00223	0.0203	CcSEcCtD
Progesterone—Vertigo—Methimazole—Graves' disease	0.00205	0.0186	CcSEcCtD
Progesterone—Alopecia—Propylthiouracil—Graves' disease	0.00197	0.0179	CcSEcCtD
Progesterone—SHBG—connective tissue—Graves' disease	0.00195	0.0317	CbGeAlD
Progesterone—Arthralgia—Methimazole—Graves' disease	0.00195	0.0177	CcSEcCtD
Progesterone—Myalgia—Methimazole—Graves' disease	0.00195	0.0177	CcSEcCtD
Progesterone—NR3C2—connective tissue—Graves' disease	0.00189	0.0307	CbGeAlD
Progesterone—Oedema—Methimazole—Graves' disease	0.00187	0.0169	CcSEcCtD
Progesterone—PGR—connective tissue—Graves' disease	0.00176	0.0286	CbGeAlD
Progesterone—Vertigo—Propylthiouracil—Graves' disease	0.00175	0.0159	CcSEcCtD
Progesterone—CYP17A1—thyroid gland—Graves' disease	0.00174	0.0283	CbGeAlD
Progesterone—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0017	0.0154	CcSEcCtD
Progesterone—Paraesthesia—Methimazole—Graves' disease	0.00167	0.0152	CcSEcCtD
Progesterone—Somnolence—Methimazole—Graves' disease	0.00166	0.0151	CcSEcCtD
Progesterone—Arthralgia—Propylthiouracil—Graves' disease	0.00165	0.015	CcSEcCtD
Progesterone—Myalgia—Propylthiouracil—Graves' disease	0.00165	0.015	CcSEcCtD
Progesterone—Dyspepsia—Methimazole—Graves' disease	0.00164	0.0149	CcSEcCtD
Progesterone—SIGMAR1—eye—Graves' disease	0.00161	0.0262	CbGeAlD
Progesterone—SLC22A3—connective tissue—Graves' disease	0.00161	0.0262	CbGeAlD
Progesterone—Oedema—Propylthiouracil—Graves' disease	0.00159	0.0144	CcSEcCtD
Progesterone—CYP2A6—adipose tissue—Graves' disease	0.00155	0.0252	CbGeAlD
Progesterone—CYP1B1—eye—Graves' disease	0.00153	0.025	CbGeAlD
Progesterone—SHBG—pituitary gland—Graves' disease	0.0015	0.0244	CbGeAlD
Progesterone—SHBG—adipose tissue—Graves' disease	0.0015	0.0243	CbGeAlD
Progesterone—Urticaria—Methimazole—Graves' disease	0.00148	0.0135	CcSEcCtD
Progesterone—CYP1B1—connective tissue—Graves' disease	0.00148	0.024	CbGeAlD
Progesterone—Body temperature increased—Methimazole—Graves' disease	0.00147	0.0134	CcSEcCtD
Progesterone—NR3C2—pituitary gland—Graves' disease	0.00146	0.0237	CbGeAlD
Progesterone—NR3C2—adipose tissue—Graves' disease	0.00145	0.0236	CbGeAlD
Progesterone—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00144	0.0131	CcSEcCtD
Progesterone—Paraesthesia—Propylthiouracil—Graves' disease	0.00142	0.0129	CcSEcCtD
Progesterone—Somnolence—Propylthiouracil—Graves' disease	0.00141	0.0128	CcSEcCtD
Progesterone—AR—connective tissue—Graves' disease	0.0014	0.0228	CbGeAlD
Progesterone—Dyspepsia—Propylthiouracil—Graves' disease	0.0014	0.0127	CcSEcCtD
Progesterone—ESR1—connective tissue—Graves' disease	0.00137	0.0223	CbGeAlD
Progesterone—PGR—pituitary gland—Graves' disease	0.00135	0.022	CbGeAlD
Progesterone—PGR—adipose tissue—Graves' disease	0.00135	0.0219	CbGeAlD
Progesterone—Pruritus—Methimazole—Graves' disease	0.00132	0.012	CcSEcCtD
Progesterone—SHBG—thyroid gland—Graves' disease	0.00129	0.0211	CbGeAlD
Progesterone—SLC22A1—adipose tissue—Graves' disease	0.00129	0.021	CbGeAlD
Progesterone—Urticaria—Propylthiouracil—Graves' disease	0.00126	0.0114	CcSEcCtD
Progesterone—NR3C2—thyroid gland—Graves' disease	0.00125	0.0204	CbGeAlD
Progesterone—Body temperature increased—Propylthiouracil—Graves' disease	0.00125	0.0114	CcSEcCtD
Progesterone—SLC22A3—adipose tissue—Graves' disease	0.00123	0.0201	CbGeAlD
Progesterone—SIGMAR1—pituitary gland—Graves' disease	0.0012	0.0195	CbGeAlD
Progesterone—SIGMAR1—adipose tissue—Graves' disease	0.00119	0.0194	CbGeAlD
Progesterone—Vomiting—Methimazole—Graves' disease	0.00119	0.0108	CcSEcCtD
Progesterone—Rash—Methimazole—Graves' disease	0.00118	0.0107	CcSEcCtD
Progesterone—Dermatitis—Methimazole—Graves' disease	0.00118	0.0107	CcSEcCtD
Progesterone—Headache—Methimazole—Graves' disease	0.00117	0.0106	CcSEcCtD
Progesterone—PGR—thyroid gland—Graves' disease	0.00117	0.019	CbGeAlD
Progesterone—CYP1B1—pituitary gland—Graves' disease	0.00114	0.0185	CbGeAlD
Progesterone—CYP1B1—adipose tissue—Graves' disease	0.00113	0.0184	CbGeAlD
Progesterone—Pruritus—Propylthiouracil—Graves' disease	0.00112	0.0102	CcSEcCtD
Progesterone—Nausea—Methimazole—Graves' disease	0.00111	0.0101	CcSEcCtD
Progesterone—AR—pituitary gland—Graves' disease	0.00108	0.0175	CbGeAlD
Progesterone—AR—adipose tissue—Graves' disease	0.00107	0.0175	CbGeAlD
Progesterone—SLC22A3—thyroid gland—Graves' disease	0.00107	0.0174	CbGeAlD
Progesterone—ESR1—pituitary gland—Graves' disease	0.00106	0.0172	CbGeAlD
Progesterone—ESR1—adipose tissue—Graves' disease	0.00105	0.0171	CbGeAlD
Progesterone—NR3C1—eye—Graves' disease	0.00105	0.0171	CbGeAlD
Progesterone—SIGMAR1—thyroid gland—Graves' disease	0.00103	0.0168	CbGeAlD
Progesterone—ABCC1—pituitary gland—Graves' disease	0.00102	0.0167	CbGeAlD
Progesterone—ABCC1—adipose tissue—Graves' disease	0.00102	0.0166	CbGeAlD
Progesterone—NR3C1—connective tissue—Graves' disease	0.00101	0.0165	CbGeAlD
Progesterone—Vomiting—Propylthiouracil—Graves' disease	0.00101	0.00915	CcSEcCtD
Progesterone—Rash—Propylthiouracil—Graves' disease	0.001	0.00908	CcSEcCtD
Progesterone—Dermatitis—Propylthiouracil—Graves' disease	0.000999	0.00907	CcSEcCtD
Progesterone—Headache—Propylthiouracil—Graves' disease	0.000994	0.00902	CcSEcCtD
Progesterone—CYP1B1—thyroid gland—Graves' disease	0.000981	0.016	CbGeAlD
Progesterone—Nausea—Propylthiouracil—Graves' disease	0.000942	0.00855	CcSEcCtD
Progesterone—AR—thyroid gland—Graves' disease	0.000929	0.0151	CbGeAlD
Progesterone—ESR1—thyroid gland—Graves' disease	0.000912	0.0148	CbGeAlD
Progesterone—ABCC1—thyroid gland—Graves' disease	0.000883	0.0144	CbGeAlD
Progesterone—CYP2C8—pituitary gland—Graves' disease	0.000872	0.0142	CbGeAlD
Progesterone—CYP1A1—adipose tissue—Graves' disease	0.000801	0.013	CbGeAlD
Progesterone—CYP3A5—adipose tissue—Graves' disease	0.000784	0.0127	CbGeAlD
Progesterone—NR3C1—pituitary gland—Graves' disease	0.000781	0.0127	CbGeAlD
Progesterone—NR3C1—adipose tissue—Graves' disease	0.000778	0.0127	CbGeAlD
Progesterone—CYP1A2—thyroid gland—Graves' disease	0.000703	0.0114	CbGeAlD
Progesterone—CYP1A1—thyroid gland—Graves' disease	0.000694	0.0113	CbGeAlD
Progesterone—NR3C1—thyroid gland—Graves' disease	0.000673	0.011	CbGeAlD
Progesterone—ABCB1—pituitary gland—Graves' disease	0.000418	0.0068	CbGeAlD
Progesterone—ABCB1—adipose tissue—Graves' disease	0.000416	0.00677	CbGeAlD
Progesterone—ABCB1—thyroid gland—Graves' disease	0.00036	0.00586	CbGeAlD
